For in vitro & in vivo laboratory research use only. Not for human or animal use. Not FDA-approved.
Dual GLP-1/GIP Receptor Agonist (20mg)
Synthetic dual GLP-1/GIP receptor agonist. Studied in vitro and in vivo for receptor binding kinetics, incretin pathway signaling, and pancreatic beta-cell biology. 5-panel verified.
All products sold strictly for in vitro & in vivo laboratory research use only. Not for human or animal use. Not FDA-approved.
FREQUENTLY ASKED QUESTIONS
This product has been independently verified at 99.1% purity via HPLC analysis. A full Certificate of Analysis (COA) is available in our COA Library.
RELATED COMPOUNDS
Dual GLP-1/GIP Receptor Agonist (10mg)
Synthetic dual GLP-1/GIP receptor agonist. Studied in vitro and in vivo for receptor binding kinetics, incretin pathway signaling, and pancreatic beta-cell biology. 5-panel verified.
Dual GLP-1/GIP Receptor Agonist (30mg)
Synthetic dual GLP-1/GIP receptor agonist. Studied in vitro and in vivo for receptor binding kinetics, incretin pathway signaling, and pancreatic beta-cell biology. 5-panel verified.
Triple GLP Receptor Agonist (10mg)
Synthetic triple receptor agonist with activity at GLP-1, GIP, and glucagon receptors. Studied in vitro for multi-receptor binding kinetics and metabolic signaling pathway research. 5-panel verified.
Triple GLP Receptor Agonist (20mg)
Synthetic triple receptor agonist with activity at GLP-1, GIP, and glucagon receptors. Studied in vitro for multi-receptor binding kinetics and metabolic signaling pathway research. 5-panel verified.
FOR RESEARCH USE ONLY. This product is strictly for in vitro and in vivo laboratory research purposes only. Not for human or animal use. Not an FDA-approved drug. Not intended to diagnose, treat, cure, or prevent any disease or condition.